XETR:SBX   SYNBIOTIC SE
SBX Analytics
15.06.2023


Consideration under WEEK


Indications
- 80% decline since its launch
- Solid levels around @EUR20, @EUR14, @EUR4 (±10%)
- Stable for around 30 days @EUR3,90 => BUY
- Weekly RSI at ATL of ~21.5 => super cheap rn => BUY
- Moving Average 9/20: 20 >> 9, crossover not predictable and could take at lease 6-8 weeks => RISK
- Moving Average 100: huge distance for crossover => RISK (bad historical stock performance)
- ZLSMA (W): Candels getting closer, crossover likely in 1-3 weeks => Chance, BUY
- Chandelier Exit (W): Still on SELL since the end of February 2023, when price holds/improves slightly => STRONG BUY
- MACD (W) (fast 12, slow 26, close): negative red section getting declining, band crossover likely => STRONG BUY
- Parabolic SAR (W): positive development as indicator nears candels, intersection / crossover likely => BUY
- Increasing trading volume indicating strong demand at current price level



TA
- Within solid downtrend for >450 days.
- Solid bounce backs each time support line got touched (yellow corcles)
- Massive breakdown after support got lost (red circle) => support line shifted / converged into new line (white)
- Stock touched new support line at green cicle, clean bounce back.
- Next reverse expected at a/ strong resistance (grey bar) AND at resistance line => same level => perspective outlook at +150% profit goal at around EUR 10 => BUY
- Next bounce back expected @EUR 5.42 (purple dotted line), while still holding sick profit of +41%

Conclusion: STRONG BUY
Most of the important indicators stating clear BUY (much more than SELL or RISK). SBX is currently under massive retail pressure but faces strong demand at current price level, which is only reasonable when considering the mentioned aspects. Most BUY rating certainly is the bounce back from shifted support level in combination with probable Chandelier Exit BUY indication.


Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.